Despite a rise in share price, Shaanxi Kanghui Pharmaceutical's P/S ratio lags behind others, possibly due to expectations of continued limited growth. A reversal in share price fortunes seems unlikely if trends persist.

The company's lower P/S ratio is due to its limited growth rates, which are expected to persist. Investors are paying less for the stock due to these rates. Unless conditions improve, the share price may stay at these levels.